Biora Therapeutics Inc (BIOR)
NASDAQ
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -221.837 | -209.814 | -150.524 | -187.947 | -47.002 | -292.931 |
Return on Equity (%) | 698.474 | 378.721 | 202.02 | 257.761 | 40.752 | 121.856 |
Return on Invested Capital (%) | -704.105 | -1221.509 | -731.067 | -246.283 | -202.548 | 321.812 |
Operating Margin (%) | -89.678 | -96.916 | -296.147 | -13312.269 | -12544.262 | -2865225 |
Net Profit Margin (%) | -100.885 | -158.924 | -259.438 | -19840.577 | -12510.492 | -3102875 |
Book Value Per Share | -1.707 | -3.089 | -2.099 | -0.501 | -12.137 | -4.535 |
Earnings Per Share | -4.506 | -7.442 | -3.457 | -1.36 | -4.274 | -5.236 |
Cash Per Share | 1.71 | 1.075 | 1.651 | 0.486 | 3.415 | 0.642 |
Working Capital Per Share | 0.38 | -0.835 | 0.962 | 0.202 | 1.659 | -1.852 |
Operating Profit Per Share | 1.413 | 1.564 | -0.223 | 0.007 | 0.034 | N/A |
EBIT Per Share | -4.322 | -4.837 | -4.125 | -0.982 | -5.516 | -5.249 |
EBITDA Per Share | -4.322 | -4.837 | -4.125 | -0.982 | -5.516 | -5.249 |
Free Cash Flow Per Share | -4.498 | -7.324 | -3.459 | -1.364 | -4.287 | -5.255 |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 28.65M | 30.75M | 55.77M | 181.87M | 8.93M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Shares Outstanding | 189.1M | 8.93M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -738050 | N/A | N/A | N/A | -255.351 | N/A |
Net Profit Margin (%) | N/A | N/A | -872050 | N/A | N/A | N/A | -772.878 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 19.11M |
Price to Earnings Ratio | -0.17 |
Price to Sales Ratio | 5.7k |
Price to Cash Ratio | 1.37 |
Price to Book Ratio | -0.2 |
Dividend Yield | - |
Shares Outstanding | 36.47M |
Average Volume (1 week) | 217.72k |
Average Volume (1 Month) | 221.3k |
52 Week Change | -73.92% |
52 Week High | 2.7129 |
52 Week Low | 0.47 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.